BridgeBio Oncology Therapeutics, Inc. (BBOT)
Nasdaq: BBOT · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2023
The company now
BridgeBio Oncology Therapeutics, Inc. is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in South San Francisco, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported a loss of $134 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.